[1]	Ding SZ, Du YQ, Lu H, et al. Chinese consensus report on family-based Helicobacter pylori infection control and management (2021 edition)[J]. Gut, 2022, 71(2):238-253.DOI:10.1136/gutjnl-2021-325630. Cited in this article [1]

[2]	Magsi I, Hussain KS, Kumar C, et al. Response of Helicobacter pylori eradication treatment in patients with normal and below-normal serum vitamin D levels[J]. Cureus, 2021, 13(4):e14777.DOI:10.7759/cureus.14777. Cited in this article [1]

[3]	Chung J, Min KW, Son BK, et al. Association between histological severity of Helicobacter pylori infection and cardiovascular risk scores in the Korean population[J]. Atherosclerosis, 2021, 333:124-130.DOI:10.1016/j.atherosclerosis.2021.08.019. Cited in this article [1]

[4]	Cuan-Baltazar Y, Soto-Vega E. Microorganisms associated to thyroid autoimmunity[J]. Autoimmun Rev, 2020, 19(9):102614.DOI:10.1016/j.autrev.2020.102614. Cited in this article [1]

[5]	Baj J, Forma A, Flieger W, et al. Helicobacter pylori Infection and extragastric diseases-A focus on the central nervous system[J]. Cells, 2021, 10(9):2191.DOI:10.3390/cells10092191. Cited in this article [1]

[6]	Franceschi F, Covino M, Roubaud BC. Review:Helicobacter pylori and extragastric diseases[J]. Helicobacter, 2019, 24 Suppl 1:e12636.DOI:10.1111/hel.12636. Cited in this article [1]

[7]	Papagni ME, Brindicci VF, Cristofori F, et al. The role of Helicobacter pylori infection in coronavirus disease 2019,cause or coincidence[J]. J Pediatr Gastroenterol Nutr, 2021, 73(4):e106.DOI:10.1097/MPG.0000000000003175. Cited in this article [1]

[8]	Chen X, Zhou X, Liao B, et al. The cross-kingdom interaction between Helicobacter pylori and Candida albicans[J]. PLoS Pathog, 2021, 17:e1009515.DOI:10.1371/journal.ppat.1009515. Cited in this article [1]

[9]	Hiengrach P, Panpetch W, Chindamporn A, et al. Helicobacter pylori,potected from antibiotics and stresses inside candida albicans vacuoles,cause gastritis in mice[J]. Int J Mol Sci, 2022, 23(15):8568.DOI:10.3390/ijms23158568. Cited in this article [1]

[10]	Reshetnyak VI, Burmistrov AI, Maev IV. Helicobacter pylori:commensal,symbiont or pathogen[J]. World J Gastroenterol, 2021, 27(7):545-560.DOI:10.3748/wjg.v27.i7.545. Cited in this article [1]

[11]	Imoto I, Oka S, Katsurahara M, et al. Helicobacter pylori infection:is there circulating vacuolating cytotoxin A or cytotoxin-associated gene A protein[J]. Gut Pathog, 2022, 14(1):43.DOI:10.1186/s13099-022-00519-8. Cited in this article [1]

[12]	Tomb JF, White O, Kerlavage AR, et al. The complete genome sequence of the gastric pathogen Helicobacter pylori[J]. Nature, 1997, 388(6642):539-547.DOI:10.1038/41483. Cited in this article [1]

[13]	Guo R, Cui X, Li X, et al. CircMAN1A2 is upregulated by Helicobacter pylori and promotes development of gastric cancer[J]. Cell Death Dis, 2022, 13(4):409.DOI:10.1038/s41419-022-04811-y. Cited in this article [1]

[14]	Takahashi-Kanemitsu A, Lu M, Knight CT, et al. The Helicobacter pylori CagA oncoprotein disrupts Wnt/PCP signaling and promotes hyperproliferation of pyloric gland base cells[J]. Sci Signal, 2023, 16(794):eabp9020.DOI:10.1126/scisignal.abp9020. Cited in this article [1]

[15]	Palframan SL, Kwok T, Gabriel K. Vacuolating cytotoxin A (vaca),a key toxin for Helicobacter pylori pathogenesis[J]. Front Cell Infect Microbiol, 2012, 2:92.DOI:10.3389/fcimb.2012.00092. Cited in this article [1]

[16]	Suerbaum S, Coombs N, Patel L, et al. Identification of antimotilins,novel inhibitors of Helicobacter pylori flagellar motility that inhibit stomach colonization in a mouse model[J]. mBio, 2022, 13(2):e0375521.DOI:10.1128/mbio.03755-21. Cited in this article [1]

[17]	Yoon HS, Shu XO, Cai H, et al. Associations of lung cancer risk with biomarkers of Helicobacter pylori infection[J]. Carcinogenesis, 2022, 43(6):538-546.DOI:10.1093/carcin/bgac047. Cited in this article [1]

[18]	Xu MY, Cao B, Chen Y, et al. Association between Helicobacter pylori infection and tumor markers:an observational retrospective study[J]. BMJ Open, 2018, 8(8):e022374.DOI:10.1136/bmjopen-2018-022374. Cited in this article [1]

[19]	Saravanakumar K, Chelliah R, MubarakAli D, et al. Unveiling the potentials of biocompatible silver nanoparticles on human lung carcinoma A549 cells and Helicobacter pylori[J]. Sci Rep, 2019, 9(1):5787.DOI:10.1038/s41598-019-42112-1. Cited in this article [1]

[20]	Oster P, Vaillant L, Riva E, et al. Helicobacter pylori infection has a detrimental impact on the efficacy of cancer immunotherapies[J]. Gut, 2022, 71(3):457-466.DOI:10.1136/gutjnl-2020-323392. Cited in this article [2]

[21]	Kobatake T, Ogino K, Sakae H, et al. Antibacterial effects of disulfiram in Helicobacter pylori[J]. Infect Drug Resist, 2021, 14:1757-1764.DOI:10.2147/IDR.S299177. Cited in this article [1]

[22]	Nguyen QA, Schmitt L, Mejías-Luque R, et al. Effects of Helicobacter pylori adhesin HopQ binding to CEACAM receptors in the human stomach[J]. Front Immunol, 2023, 14:1113478.DOI:10.3389/fimmu.2023.1113478. Cited in this article [1]

[23]	Wan Y, Shang J, Graham R, et al. Receptor recognition by the novel coronavirus from Wuhan:an analysis based on decade-long structural studies of SARS coronavirus[J]. J Virol, 2020, 94(7):e00127-20.DOI:10.1128/JVI.00127-20. Cited in this article [1]

[24]	Balamtekin N, Artuk C, Arslan M, et al. The effect of Helicobacter pylori on the presentation and clinical course of coronavirus disease 2019 infection[J]. J Pediatr Gastroenterol Nutr, 2021, 72(4):511-513.DOI:10.1097/MPG.0000000000003005. Cited in this article [1]

[25]	Gonzalez I, Lindner C, Schneider I, et al. Inflammation at the crossroads of Helicobacter pylori and COVID-19[J]. Future Microbiol, 2022, 17(2):77-80.DOI:10.2217/fmb-2021-0250. Cited in this article [1]

[26]	Lee SW, Ha EK, Yeniova AÖ, et al. Severe clinical outcomes of COVID-19 associated with proton pump inhibitors:a nationwide cohort study with propensity score matching[J]. Gut, 2021, 70(1):76-84.DOI:10.1136/gutjnl-2020-322248. Cited in this article [1]

[27]	Sciorati C, De Lorenzo R, Lorè NI, et al. The elusive role of proton pump inhibitors in COVID-19:Can plasma Chromogranin A levels hold the key[J]. Pharmacol Res, 2023, 187:106601.DOI:10.1016/j.phrs.2022.106601. Cited in this article [1]

[28]	De LR, Sciorati C, Ramirez GA, et al. Chromogranin A plasma levels predict mortality in COVID-19[J]. PLoS One, 2022, 17(4):e0267235.DOI:10.1371/journal.pone.0267235. Cited in this article [1]

[29]	Nemergut M, Batkova T, Vigasova D, et al. Increased occurrence of Treponema spp.and double-species infections in patients with Alzheimer's disease[J]. Sci Total Environ, 2022, 844:157114.DOI:10.1016/j.scitotenv.2022.157114. Cited in this article [1]

[30]	Beydoun MA, Beydoun HA, Weiss J, et al. Helicobacter pylori,periodontal pathogens,and their interactive association with incident all-cause and Alzheimer's disease dementia in a large national survey[J]. Mol Psychiatry, 2021, 26(10):6038-6053.DOI:10.1038/s41380-020-0736-2. Cited in this article [1]

[31]	Fu P, Gao M, Yung KKL. Association of intestinal disorders with Parkinson's disease and Alzheimer's disease:A systematic review and meta-analysis[J]. ACS Chem Neurosci, 2020, 11(3):395-405.DOI:10.1021/acschemneuro.9b00607. Cited in this article [1]

[32]	Xie J, Li Q, Haesebrouck F, et al. The tremendous biomedical potential of bacterial extracellular vesicles[J]. Trends Biotechnol, 2022, 40(10):1173-1194.DOI:10.1016/j.tibtech.2022.03.005. Cited in this article [2]

[33]	Uberti AF, Callai-Silva N, Grahl MVC, et al. Helicobacter pylori Urease:potential contributions to Alzheimer's disease[J]. Int J Mol Sci, 2022, 23(6):3091.DOI:10.3390/ijms23063091. Cited in this article [1]

[34]

Ju Z, Shen L, Zhou M, et al. Helicobacter pylori and Alzheimer's disease-related metabolic dysfunction:activation of TLR4/Myd88 inflammation pathway from p53 perspective and a case study of low-dose radiation intervention[J]. ACS Chem Neurosci, 2022, 13(7):1065-1081.DOI:10.1021/acschemneuro.2c00082. Cited in this article [1]

[35]	Shiota S, Murakami K, Yoshiiwa A, et al. The relationship between Helicobacter pylori infection and Alzheimer's disease in Japan[J]. J Neurol, 2011, 258(8):1460-1463.DOI:10.1007/s00415-011-5957-5. Cited in this article [1]

[36]	Zhong R, Chen Q, Zhang X, et al. Helicobacter pylori infection is associated with a poor response to levodopa in patients with Parkinson's disease:a systematic review and meta-analysis[J]. J Neurol, 2022, 269(2):703-711.DOI:10.1007/s00415-021-10473-1. Cited in this article [1]

[37]	Bai F, Li X. Association of Helicobacter pylori treatment with Parkinsonism and related disorders:a systematic review and meta-analysis[J]. Life Sci, 2021, 281:119767.DOI:10.1016/j.lfs.2021.119767. Cited in this article [1]

[38]	Smeyne RJ, Noyce AJ, Byrne M, et al. Infection and Risk of Parkinson's Disease[J]. J Parkinsons Dis, 2021, 11(1):31-43.DOI:10.3233/JPD-202279. Cited in this article [1]

[39]	Nyholm D, Hellström PM. Effects of Helicobacter pylori on levodopa pharmacokinetics[J]. J Parkinsons Dis, 2021, 11(1):61-69.DOI:10.3233/JPD-202298. Cited in this article [1]

[40]	Arjmandi D, Abdollahi A, Ardekani A, et al. Helicobacter pylori infection and risk of multiple sclerosis:an updated meta-analysis[J]. Helicobacter, 2022, 27(6):e12927.DOI:10.1111/hel.12927. Cited in this article [1]

[41]	Kountouras J, Papaefthymiou A, Gavalas E, et al. Helicobacter pylori infection as a potential risk factor for multiple sclerosis[J]. Med Hypotheses, 2020, 143:110135.DOI:10.1016/j.mehy.2020.110135. Cited in this article [2]

[42]	Cavestro C, Prandi G, Manildo M, et al. A cross-sectional study on the association between Helicobacter pylori infection and headache[J]. Neurol Sci, 2022, 43(10):6031-6038.DOI:10.1007/s10072-022-06153-1. Cited in this article [1]

[43]	Arzani M, Jahromi SR, Ghorbani Z, et al. School of advanced studies of the european headache federation (EHF-SAS).Gut-brain axis and migraine headache:a comprehensive review[J]. J Headache Pain, 2020, 21(1):15.DOI:10.1186/s10194-020-1078-9. Cited in this article [2]

[44]	Baj J, Forma A, Flieger W, et al. Helicobacter pylori infection and extragastric dseases-a focus on the central nervous system[J]. Cells, 2021, 10(9):2191.DOI:10.3390/cells10092191. Cited in this article [1]

[45]	Bai X, Jiang L, Ruan G, et al. Helicobacter pylori may participate in the development of inflammatory bowel disease by modulating the intestinal microbiota[J]. Chin Med J (Engl), 2022, 135(6):634-638.DOI:10.1097/CM9.0000000000002008. Cited in this article [1]

[46]	Aaldijk E, Vermeiren Y. The role of serotonin within the microbiota-gut-brain axis in the development of Alzheimer's disease:a narrative review[J]. Ageing Res Rev, 2022, 75:101556.DOI:10.1016/j.arr.2021.101556. Cited in this article [1]

[47]	He C, Xie Y, Zhu Y, et al. Probiotics modulate gastrointestinal microbiota after Helicobacter pylori eradication:a multicenter randomized double-blind placebo-controlled trial[J]. Front Immunol, 2022, 13:1033063.DOI:10.3389/fimmu.2022.1033063. Cited in this article [1]

[48]	Duan M, Li Y, Liu J, et al. Transmission routes and patterns of Helicobacter pylori[J]. Helicobacter, 2023(1): e12945.DOI:10.1111/hel.12945. Cited in this article [1]

[49]	Head S. Helicobacter pylori infection:a sexually transmitted disease[J]. BMJ, 2008, 337:a 2077.DOI:10.1136/bmj.a2077. Cited in this article [1]

[50]	Sgambato D, Visciola G, Ferrante E, et al. Prevalence of Helicobacter pylori infection in sexual partners of H.pylori-infected subjects:role of gastroesophageal reflux[J]. United European Gastroenterol J, 2018, 6(10):1470-1476.DOI:10.1177/2050640618800628. Cited in this article [2]

[51]	Hamada M, Nomura R, Matayoshi S, et al. Detection of Helicobacter pylori from extracted teeth of a patient with idiopathic thrombocytopenic purpura[J]. Microorganisms, 2022, 10(11):2285.DOI:10.3390/microorganisms10112285. Cited in this article [1]

[52]	Hamada M, Nomura R, Ogaya Y, et al. Potential involvement of Helicobacter pylori from oral specimens in overweight body-mass index[J]. Sci Rep, 2019, 9(1):4845.DOI:10.1038/s41598-019-41166-5. Cited in this article [1]

[53]	Sánchez-Alonzo K, Matamala-Valdés L, Parra-Sepúlveda C, et al. Intracellular presence of Helicobacter pylori and its virulence-associated genotypes within the vaginal yeast of term pregnant women[J]. Microorganisms, 2021, 9(1):131.DOI:10.3390/microorganisms9010131. Cited in this article [1]

[54]	Chang YW, Han YS, Lee DK, et al. Role of Helicobacter pylori infection among offspring or siblings of gastric cancer patients[J]. Int J Cancer, 2002, 101(5):469-474.DOI:10.1002/ijc.10637. Cited in this article [1]

[55]	Sánchez-Alonzo K, Parra-Sepúlveda C, Vega S, et al. In vitro incorporation of Helicobacter pylori into Candida albicans caused by acidic pH stress[J]. Pathogens, 2020, 9(6):489.DOI:10.3390/pathogens9060489. Cited in this article [2]

[56]	Sánchez-Alonzo K, Silva-Mieres F, Arellano-Arriagada L, et al. Nutrient deficiency promotes the entry of Helicobacter pylori cells into Candida yeast cells[J]. Biology (Basel), 2021, 10(5):426.DOI:10.3390/biology10050426. Cited in this article [2]

[57]	Yang T, Li J, Zhang Y, et al. Intracellular presence of Helicobacter pylori antigen and genes within gastric and vaginal Candida[J]. PLoS One, 2024, 19(2):e0298442.DOI:10.1371/journal.pone.0298442. Cited in this article [1]

[58]	Abrantes PMDS, Africa CWJ. Measuring Streptococcus mutans,Streptococcus sanguinis and Candida albicans biofilm formation using a real-time impedance-based system[J]. J Microbiol Methods, 2020, 169:105815.DOI:10.1016/j.mimet.2019.105815. Cited in this article [1]

[59]	Assidi M. Infertility in men:advances towards a comprehensive and integrative strategy for precision theranostics[J]. Cells, 2022, 11(10):1711.DOI:10.3390/cells11101711. Cited in this article [1]

[60]	Corsini C, Boeri L, Candela L, et al. Is there a relevant clinical impact in differentiating idiopathic versus unexplained male infertility[J]. World J Mens Health, 2023, 41(2):354-362.DOI:10.5534/wjmh.220069. Cited in this article [1]

[61]	El-Garem Y, El-Sawy M, Mostafa T. et al. Seminal Helicobacter pylori treatment improves sperm mtility in infertile asthenozoospermic men[J]. Urology, 2014, 84(6):1347-1350.DOI:10.1016/j.urology.2014.09.004. Cited in this article [1]

[62]	Moretti E, Figura N, Campagna MS, et al. Infectious burden and semen parameters[J]. Urology, 2017, 100:90-96.DOI:10.1016/j.urology.2016.10.032. Cited in this article [1]

[63]	Liu JM, Wu CT, Hsu RJ, et al. Association between Helicobacter pylori infection and mortality risk in prostate cancer patients receiving androgen deprivation therapy:a real-world evidence study[J]. Cancer Med, 2021, 10(22):8162-8171.DOI:10.1002/cam4.4318. Cited in this article [1]

[64]

Youssefi M, Tafaghodi M, Farsiani H, et al. Helicobacter pylori infection and autoimmune diseases;Is there an association with systemic lupus erythematosus,rheumatoid arthritis,autoimmune atrophy gastritis and autoimmune pancreatitis?A systematic review and meta-analysis study[J]. J Microbiol Immunol Infect, 2021, 54(3):359-369.DOI:10.1016/j.jmii.2020.08.011. Cited in this article [1]

[65]	Feng C, Lv PP, Huang CC, et al. Sperm parameters and anti-Müllerian hormone remain stable with Helicobacter pylori infection:a cross-sectional study[J]. BMC Urol, 2020, 20(1):188.DOI:10.1186/s12894-020-00725-z. Cited in this article [1]

[66]	Ding Y, Yao X, Zhang H, et al. Maternal antibiotic treatment during pregnancy attenuates the transport and absorption of maternal antibody IgG through TLR4 and TLR2 receptor[J]. Front Microbiol, 2023, 14:1109273.DOI:10.3389/fmicb.2023.1109273. Cited in this article [1]

[67]	Breddels EM, Simin J, Fornes R, et al. Population-based cohort study:proton pump inhibitor use during pregnancy in Sweden and the risk of maternal and neonatal adverse events[J]. BMC Med, 2022, 20(1):492.DOI:10.1186/s12916-022-02673-x. Cited in this article [1]

[68]	Escoffier J, Arnaud B, Kaba M, et al. Pantoprazole,a proton-pump inhibitor,impairs human sperm motility and capacitation in vitro[J]. Andrology, 2020, 8(6):1795-1804.DOI:10.1111/andr.12855. Cited in this article [1]

[69]

Kumar A, Kumar R, Flanagan J, et al. Esomeprazole reduces sperm motility index by targeting the spermic cholinergic machinery:a mechanistic study for the association between use of proton pump inhibitors and reduced sperm motility index[J]. Biochem Pharmacol, 2020, 182:114212.DOI:10.1016/j.bcp.2020.114212. Cited in this article [1]

[70]	Obuchowska A, Gorczyca K, Standyło A, et al. Effects of probiotic supplementation during pregnancy on the future maternal risk of metabolic syndrome[J]. Int J Mol Sci, 2022, 23(15):8253.DOI:10.3390/ijms23158253. Cited in this article [1]

[71]	Hao Y, Feng Y, Yan X, et al. Gut microbiota-testis axis:FMT improves systemic and testicular micro-environment to increase semen quality in type 1 diabetes[J]. Mol Med, 2022, 28(1):45.DOI:10.1186/s10020-022-00473-w. Cited in this article [1]

[72]	Ji J, Yang H. Using Probiotics as Supplementation for Helicobacter pylori antibiotic therapy[J]. Int J Mol Sci, 2020, 21(3):1136.DOI:10.3390/ijms21031136. Cited in this article [1]

[73]	Barnes RJ, Uff JS, Dent JC, et al. Long-term follow up of patients with gastritis associated with Helicobacter pylori infection[J]. Br J Gen Pract, 1991, 41(348):286-288.

[74]	Glynn JR. Helicobacter pylori and the heart[J]. Lancet, 1994, 344(8916):146.DOI:10.1016/s0140-6736(94)92754-5.

[75]	Sutter MC. Lessons for atherosclerosis research from tuberculosis and peptic ulcer[J]. CMAJ. 1995, 152(5):667-670.

[76]	Niemelä S, Karttunen T, Korhonen T, et al. Could Helicobacter pylori infection increase the risk of coronary heart disease by modifying serum lipid concentrations[J]. Heart, 1996, 75(6):573-575.DOI:10.1136/hrt.75.6.573.

[77]

Birnie DH, Holme ER, McKay IC, et al. Association between antibodies to heat shock protein 65 and coronary atherosclerosis.Possible mechanism of action of Helicobacter pylori and other bacterial infections in increasing cardiovascular risk[J]. Eur Heart J, 1998, 19(3):387-394.DOI:10.1053/euhj.1997.0618.

[78]	Kountouras J, Papaefthymiou A, Polyzos SA, et al. Impact of Helicobacter pylori-related metabolic syndrome parameters on arterial hypertension[J]. Microorganisms, 2022, 9(11):2351.DOI:10.3390/microorganisms9112351. Cited in this article [1]

[79]	Xiong X, Chen J, He M, et al. Helicobacter pylori infection and the prevalence of hypertension in Chinese adults:the Dongfeng-Tongji cohort[J]. J Clin Hypertens (Greenwich), 2020, 22(8):1389-1395.DOI:10.1111/jch.13928. Cited in this article [1]

[80]	González A, Casado J, Gündüz MG, et al. 1,4-dihydropyridine as a promising scaffold for novel antimicrobials against Helicobacter pylori[J]. Front Microbiol, 2022, 13:874709.DOI:10.3389/fmicb.2022.874709. Cited in this article [1]

[81]

Gajewski AŁ, Gawrysiak M, Krupa A, et al. Accumulation of deleterious effects in gastric epithelial cells and vascular endothelial cells in vitro in the milieu of Helicobacter pylori components,7-ketocholesterol and acetylsalicylic acid[J]. Int J Mol Sci, 2022, 23(11):6355.DOI:10.3390/ijms23116355. Cited in this article [1]

[82]	Li B, Xia Y, Hu B. Infection and atherosclerosis:TLR-dependent pathways[J]. Cell Mol Life Sci, 2020, 77(14):2751-2769.DOI:10.1007/s00018-020-03453-7. Cited in this article [1]

[83]	Gonciarz W, Lechowicz Ł, Urbaniak M, et al. Searching for serum biomarkers linking coronary heart disease and Helicobacter pylori infection using infrared spectroscopy and artificial neural networks[J]. Sci Rep, 2022, 12(1):18284.DOI:10.1038/s41598-022-23191-z. Cited in this article [1]

[84]	Kim SB, Kim N, Park J, et al. Preventive effect of Helicobacter pylori eradication on the coronary heart diseases depending on age and sex with a median follow-up of 51 months[J]. Helicobacter, 2023, 28(4):e12969.DOI:10.1111/hel.12969. Cited in this article [1]

[85]	Chen Y, Yang C, You N, et al. Relationship between Helicobacter pylori and glycated hemoglobin:a cohort study[J]. Front Cell Infect Microbiol, 2023, 13:1196338.DOI:10.3389/fcimb.2023.1196338. Cited in this article [1]

[86]	Goldenring JR, Mills JC. Cellular plasticity,reprogramming,and regeneration:metaplasia in the stomach and beyond[J]. Gastroenterology, 2022, 162(2):415-430.DOI:10.1053/j.gastro.2021.10.036. Cited in this article [1]

[87]	Azami M, Baradaran HR, Dehghanbanadaki H, et al. Association of Helicobacter pylori infection with the risk of metabolic syndrome and insulin resistance:an updated systematic review and meta-analysis[J]. Diabetol Metab Syndr, 2021, 13(1):145.DOI:10.1186/s13098-021-00765-x. Cited in this article [1]

[88]	Esmaeili Dooki MR, Alijanpour Aghamaleki M, Noushiravani N, et al. Helicobacter pylori infection and type 1 diabetes mellitus in children[J]. J Diabetes Metab Disord, 2020, 19(1):243-247.DOI:10.1007/s40200-020-00497-1. Cited in this article [1]

[89]	Gamil NM, Abd El Fattah MA, Ahmed MAE, et al. Lansoprazole enhances the antidiabetic effect of dapagliflozin in fortified diet-fed streptozotocin-treated diabetic rats[J]. J Biochem Mol Toxicol, 2020, 34(4):e22451.DOI:10.1002/jbt.22451. Cited in this article [1]

[90]

Zhang J, Hai X, Wang S, et al. Helicobacter pylori infection increase the risk of subclinical hyperthyroidism in middle-aged and elderly women independent of dietary factors:Results from the Tianjin chronic low-grade systemic inflammation and health cohort study in China[J]. Front Nutr, 2023, 10:1002359.DOI:10.3389/fnut.2023.1002359. Cited in this article [2]

[91]	Silva IN, Marçal LV, Queiroz DMM. Helicobacter pylori infection is associated with thyroid dysfunction in children with congenital hypothyroidism[J]. Front Pediatr, 2022, 10:875232.DOI:10.3389/fped.2022.875232. Cited in this article [2]

[92]	Wenzek C, Boelen A, Westendorf AM, et al. The interplay of thyroid hormones and the immune system-where we stand and why we need to know about it[J]. Eur J Endocrinol, 2022, 186(5):R65-R77.DOI:10.1530/EJE-21-1171. Cited in this article [1]

[93]	Yamaguchi H, Osaki T, Kai M, et al. Immune response against a cross-reactive epitope on the heat shock protein 60 homologue of Helicobacter pylori[J]. Infect Immun, 2000, 68(6):3448-3454.DOI:10.1128/IAI.68.6.3448-3454.2000. Cited in this article [1]